Dose: A critical factor in cancer chemotherapy

Antileukemic Effect of Graft-versus-Host Disease in Human Recipients of Allogeneic-Marrow Grafts

P L Weiden, Nancy Flournoy, E D Thomas et al. · New England Journal of Medicine · 1979 · 1.5K citations

Medicine, Hematology, Immunology +13

Combination Chemotherapy in the Treatment of Advanced Hodgkin's Disease

Vincent T. DeVita · Annals of Internal Medicine · 1970 · 1.4K citations

Medicine, Oncology, Pharmacology +17

Combination chemotherapy of Hodgkin's disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide versus MOPP

Gianni Bonadonna, R Zucali, S. Monfardini et al. · Cancer · 1975 · 760 citations · Full text

Medicine, Oncology, Pharmacology +14

Comparison of the Sensitivity of Normal Hematopoietic and Transplanted Lymphoma Colony-Forming Cells to Chemotherapeutic Agents Administered <italic>In Vivo</italic><xref ref-type="fn" rid="FN2">2</xref>

JNCI Journal of the National Cancer Institute · 1966 · 528 citations

Medicine, Hematology, Oncology +10

Tumor size, sensitivity to therapy, and design of treatment schedules.

Larry Norton, Richard Simon · PubMed · 1977 · 454 citations

Medicine, Oncology, Cancer Pharmacology +13